Osaka, Japan

Mariko Kobayashi

This inventor holds 2 USPTO granted patents. Top assignee: Sumitomo Pharma Co., Ltd.. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mariko Kobayashi. Retrieved from https://idiyas.com/inventor/mariko-kobayashi-o65phzee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mariko Kobayashi: Innovator in Medicinal Chemistry

Introduction

Mariko Kobayashi is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments for central nervous system diseases. With a total of 2 patents to her name, her work is recognized for its potential impact on healthcare.

Latest Patents

Kobayashi's latest patents focus on nitrogen-containing saturated heterocyclyl derivatives. These inventions relate to a medicament designed to treat or prevent central nervous system diseases caused by abnormal protein aggregation in the brain. The active ingredient in her formulations includes compounds that have shown efficacy in suppressing or reducing the accumulation of these harmful proteins.

Career Highlights

Throughout her career, Mariko Kobayashi has been associated with Sumitomo Pharma Co., Ltd., where she has played a vital role in advancing pharmaceutical research. Her innovative approaches and dedication to improving patient outcomes have established her as a key figure in her field.

Collaborations

Kobayashi has collaborated with notable colleagues, including Hitoshi Watanabe and Shuya Yamada. These partnerships have fostered a collaborative environment that enhances the research and development of new medicinal products.

Conclusion

Mariko Kobayashi's contributions to medicinal chemistry and her innovative patents highlight her commitment to addressing critical health challenges. Her work continues to inspire advancements in the treatment of central nervous system diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…